Export 3 results:
[ Autore![(Desc)](https://www.burlo.trieste.it/sites/all/modules/biblio/misc/arrow-desc.png)
Filtri: Autore è di Iasio, Maria Grazia [Clear All Filters]
Nutlin-3 differentially modulates miRNA34a and miRNA181 versus miR26a and miR155 in p53 proficient and p53 deficient B chronic lymphocytic leukemia (B-CLL) samples. Invest New Drugs 2012;30(4):1761-5.
. The non-genotoxic activator of the p53 pathway Nutlin-3 shifts the balance between E2F7 and E2F1 transcription factors in leukemic cells. Invest New Drugs 2013;31(2):458-60.
. .